Deferred Tax Assets, Valuation Allowance of Sunshine Biopharma Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Sunshine Biopharma Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • Sunshine Biopharma Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $6,967,294, a 8.9% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Sunshine Biopharma Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $6,967,294 +$569,920 +8.9% 31 Dec 2024 10-K 01 Apr 2025 2024 FY
Q4 2023 $6,397,374 +$800,943 +14% 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q4 2022 $5,596,431 31 Dec 2022 10-K 04 Apr 2023 2022 FY
Q3 2015 $2,869,575 30 Sep 2015 10-Q 04 Nov 2015 2015 Q3
Q4 2014 $3,257,895 +$2,159,065 +196% 31 Dec 2014 10-Q 04 Nov 2015 2015 Q3
Q4 2013 $1,098,830 +$498,297 +83% 31 Dec 2013 10-K 19 Mar 2014 2013 FY
Q4 2012 $600,533 +$489,292 +440% 31 Dec 2012 10-K 19 Mar 2014 2013 FY
Q4 2011 $111,241 31 Dec 2011 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.